Categories
France Hydroxychloroquine News Article RESEARCH

Chloroquine for the 2019 novel coronavirus SARS-CoV-2

French research team Colson, Rolain, Raoult propose the following in the International Journal of Antimicrobial Agents: In the current episode of novel coronavirus (SARS-CoV-2) emergence [2], we find a spectacular example of possible repositioning of drugs, particularly chloroquine. We had 20 years ago proposed to systematically test chloroquine in viral infections because it had been shown […]

Categories
Argentina Belgium China France Global Hungary Hydroxychloroquine Israel Italy Official Portugal Prophylaxis RESEARCH Romania Russia Serbia Spain The Netherlands Tunisia Turkey

HIBISCUS: Hydroxychloroquine for the Secondary Prevention of Thrombotic and Obstetrical Events in Primary Antiphospholipid Syndrome

Hydroxychloroquine (HCQ) appears as an additional therapy, as it possesses immunomodulatory and anti-thrombotic various effects [4-16].

Categories
Chloroquine Hydroxychloroquine Italy Medical Study Official RESEARCH Treatment

Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review

Chloroquine and hydroxychloroquine, with an original indication to prevent or cure malaria, have been successfully used to treat several infectious diseases.

Categories
Belgium Chloroquine Hydroxychloroquine Medical Study Official Prophylaxis RESEARCH Treatment UK US

Repurposing Drugs in Oncology (ReDO)—chloroquine and hydroxychloroquine as anti-cancer agents

Scientific evidence also supports the use of CQ and HCQ in the treatment of cancer.

Categories
Chloroquine Global Hydroxychloroquine Medical Study Official RESEARCH Treatment

Chloroquine and hydroxychloroquine for cancer therapy

Here, we summarize the results or design of clinical studies recently completed or initiated to evaluate the therapeutic activity of chloroquine derivatives in cancer patients.

Categories
Hydroxychloroquine Medical Study Official RESEARCH US

Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy–treated immunologic nonresponders

HCQ reduces lipopolysaccharide/TLR-mediated immune activation; this compound could be a useful immunomodulant in HIV-infected patients.

Categories
Medical Study Official RESEARCH The Netherlands Treatment US Zinc

Zn2+ Inhibits Coronavirus and Arterivirus RNA Polymerase Activity In Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell Culture

This suggests that intracellular Zn2+ levels affect a common step in the replicative cycle of these viruses.

Categories
Belgium Chloroquine Hydroxychloroquine Italy Medical Study Official RESEARCH Treatment

Effects of chloroquine on viral infections: an old drug against today’s diseases

The anti-HIV effect of chloroquine/hydroxychloroquine is modest by itself but is additive or synergistic when combined with selected antiretrovirals.

Categories
Chloroquine Italy RESEARCH Treatment

Effects of Chloroquine on Viral Infections: An Old Drug Against Today’s Diseases?

Source: NIH Savarino A, Boelaert JR, Cassone A, Majori G, Cauda R. Effects of chloroquine on viral infections: an old drug against today’s diseases?. Lancet Infect Dis. 2003;3(11):722‐727. doi:10.1016/s1473-3099(03)00806-5 Abstract Chloroquine is a 9-aminoquinoline known since 1934. Apart from its well-known antimalarial effects, the drug has interesting biochemical properties that might be applied against some viral […]

Categories
Chloroquine Official RESEARCH US

Mechanism of Uncoating of Influenza B Virus in MDCK Cells: Action of Chloroquine

Source: PubMed.com Abstract Exposure of influenza B virus-infected MDCK cells to chloroquine at the time of infection resulted in significant inhibition of infection. The appearance of input virus in the intracellular vesicles was not affected in the presence of the drug, but primary transcription of the virus genome did not occur. Chloroquine caused a rapid […]